Although optimal methods of risk classification and treatment have been difficult to define, uniform standards for management of the tumor lysis syndrome are beginning to evolve. Indeed ...

Please provide your email address to receive an email when new articles are posted on . Tumor lysis syndrome is a group of metabolic abnormalities that arise from tumor breakdown that exceeds the ...

If they can’t keep up, you can develop something called tumor lysis syndrome (TLS). This syndrome is most common in people with blood-related cancers, including some leukemias and lymphomas.

Although tumor lysis syndrome may be dangerous and fatal if not treated early, experts note that it is a sign of successful treatment in patients with leukemia and lymphoma. Cancer treatment almost ...

Q: Who treats the patient with tumor lysis syndrome? A: Oncologists treat the patients with tumor lysis syndrome but if renal complications occur, a nephrologist’s consultation is required.

The research raises the possibility that the type of therapy used can increase the risk of tumor lysis syndrome from low to moderate in men with multiple myeloma (MM). Therapy with bortezomib ...

Tumor lysis syndrome represents a potentially fatal complication of cancer treatment that is usually seen in patients with rapidly growing, extensive and chemosensitive malignant tumors.

Tumor lysis syndrome (TLS) is a rare but potentially fatal complication that can occur during cancer treatment. Doctors can treat TLS using a range of medications. TLS happens when cancer cells ...

The manifestation of tumor lysis syndrome (TLS) occurs when the destruction of tumor cells releases breakdown products that overwhelm the excretory mechanisms of the body. A cardinal sign is ...